Professor Andrew Pollard Interview re Oxford-AstraZeneca vaccine Part 2

The transcript discusses the roles of the government and manufacturers in vaccine delivery, ongoing research on vaccine efficacy and new variants, and the importance of developing a non-profit vaccine. It highlights the collaboration between Oxford University and AstraZeneca to ensure affordable vaccine distribution. The conversation also compares current efforts to past vaccine developments, emphasizing the pressure and significance of the work for humanity. Finally, it touches on public perceptions of science and scientists.

What role does the government play in the mass vaccination process?

Why is it important to understand the persistence of protection from vaccines?

What challenges are associated with new variants of viruses in relation to vaccine effectiveness?

What was the significance of developing a not-for-profit vaccine according to the speaker?

How does the pressure faced in vaccine development during a pandemic differ from normal circumstances?